Total Payments
$5,488
2024 Payments
$16.24
Companies
35
Transactions
408
Medicare Patients
16,455
Medicare Billing
$620,637
Payment Breakdown by Category
Food & Beverage$5,465 (99.6%)
Education$23.33 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,465 | 404 | 99.6% |
| Education | $23.33 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $815.10 | 63 | $0 (2021) |
| Novo Nordisk Inc | $682.24 | 49 | $0 (2022) |
| PFIZER INC. | $618.28 | 63 | $0 (2024) |
| GlaxoSmithKline, LLC. | $503.45 | 39 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $483.67 | 32 | $0 (2019) |
| Mylan Specialty L.P. | $455.91 | 33 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $327.27 | 22 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $326.99 | 28 | $0 (2021) |
| Amgen Inc. | $231.75 | 9 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $216.00 | 15 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.24 | 1 | PFIZER INC. ($16.24) |
| 2023 | $73.48 | 5 | GlaxoSmithKline, LLC. ($41.56) |
| 2022 | $209.70 | 12 | GlaxoSmithKline, LLC. ($96.32) |
| 2021 | $656.16 | 44 | Novo Nordisk Inc ($132.52) |
| 2020 | $149.47 | 10 | Sunovion Pharmaceuticals Inc. ($31.20) |
| 2019 | $1,046 | 76 | AstraZeneca Pharmaceuticals LP ($198.43) |
| 2018 | $1,668 | 127 | AstraZeneca Pharmaceuticals LP ($324.81) |
| 2017 | $1,669 | 133 | SANOFI-AVENTIS U.S. LLC ($288.73) |
All Payment Transactions
408 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: PAIN | ||||||
| 12/06/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardio-renal | ||||||
| 04/18/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: PAIN | ||||||
| 11/15/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Cardio-renal | ||||||
| 10/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Cardio-renal | ||||||
| 09/18/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/31/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Gastroenterology | ||||||
| 07/21/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/12/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: RESPIRATORY | ||||||
| 06/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: RESPIRATORY | ||||||
| 05/04/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Obesity | ||||||
| 04/26/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: RESPIRATORY | ||||||
| 04/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: RESPIRATORY | ||||||
| 03/10/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: RESPIRATORY | ||||||
| 12/08/2021 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/07/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/11/2021 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: UROLOGY | ||||||
| 11/09/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: RESPIRATORY | ||||||
| 11/03/2021 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/28/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 3,683 | 5,075 | $401,060 | $138,284 |
| 2022 | 51 | 4,162 | 6,031 | $468,463 | $159,394 |
| 2021 | 61 | 4,506 | 6,572 | $485,839 | $171,279 |
| 2020 | 53 | 4,104 | 6,283 | $493,412 | $151,680 |
Total Patients
16,455
Total Services
23,961
Medicare Billing
$620,637
Procedure Codes
213
All Medicare Procedures & Services
213 procedure records from CMS Medicare Utilization — Page 2 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 58 | 64 | $1,600 | $530.56 | 33.2% |
| 83735 | Magnesium level | Office | 2023 | 70 | 79 | $1,580 | $515.20 | 32.6% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 26 | 26 | $1,430 | $491.92 | 34.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 22 | 22 | $990.00 | $480.18 | 48.5% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 21 | 21 | $1,591 | $466.53 | 29.3% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 27 | 28 | $1,260 | $448.20 | 35.6% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 15 | 15 | $1,222 | $440.39 | 36.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 40 | 42 | $1,639 | $354.77 | 21.6% |
| 73620 | X-ray of foot, 2 views | Office | 2023 | 15 | 20 | $1,142 | $351.64 | 30.8% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 17 | 18 | $1,165 | $346.16 | 29.7% |
| 72040 | X-ray of upper spine, 2-3 views | Office | 2023 | 12 | 13 | $972.12 | $301.64 | 31.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 18 | 19 | $855.00 | $280.82 | 32.8% |
| 83550 | Iron binding capacity | Office | 2023 | 20 | 25 | $625.00 | $214.25 | 34.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 30 | 30 | $450.00 | $183.30 | 40.7% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 11 | 11 | $483.89 | $171.60 | 35.5% |
| 84484 | Troponin (protein) analysis, quantitative | Office | 2023 | 13 | 14 | $490.00 | $171.08 | 34.9% |
| 83540 | Iron level | Office | 2023 | 20 | 24 | $360.00 | $152.16 | 42.3% |
| 73020 | X-ray of shoulder, 1 view | Office | 2023 | 14 | 14 | $669.14 | $118.20 | 17.7% |
| 84550 | Uric acid level, blood | Office | 2023 | 20 | 21 | $315.00 | $90.76 | 28.8% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 13 | 13 | $195.00 | $54.34 | 27.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 17 | 36 | $432.00 | $34.09 | 7.9% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 12 | 50 | $1,050 | $18.15 | 1.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 31 | 149 | $1,788 | $12.89 | 0.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 402 | 718 | $161,292 | $52,153 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 299 | 603 | $92,862 | $32,455 | 34.9% |
About Dr. David Walt, MD
Dr. David Walt, MD is a Family Medicine healthcare provider based in Cleveland, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205895448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Walt, MD has received a total of $5,488 in payments from pharmaceutical and medical device companies, with $16.24 received in 2024. These payments were reported across 408 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,465).
As a Medicare-enrolled provider, Walt has provided services to 16,455 Medicare beneficiaries, totaling 23,961 services with total Medicare billing of $620,637. Data is available for 4 years (2020–2023), covering 213 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Cleveland, MS
- Active Since 03/17/2006
- Last Updated 12/11/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1205895448
Products in Payments
- FARXIGA (Drug) $321.90
- ENTRESTO (Drug) $312.85
- Victoza (Drug) $264.61
- Yupelri (Drug) $259.28
- SOLIQUA (Drug) $232.16
- TRELEGY ELLIPTA (Drug) $209.22
- JARDIANCE (Drug) $195.39
- BEVESPI AEROSPHERE (Drug) $183.90
- Ozempic (Drug) $180.85
- TOUJEO (Drug) $177.80
- LONHALA MAGNAIR (Drug) $167.01
- TOVIAZ (Drug) $161.76
- BYDUREON (Drug) $160.52
- VIAGRA (Drug) $158.97
- Repatha (Biological) $151.68
- CHANTIX (Drug) $142.65
- ANORO (Drug) $141.24
- Dymista (Drug) $116.09
- BREO (Drug) $111.43
- Vascepa (Drug) $100.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cleveland
Dominic King, D.o, D.O
Family Medicine — Payments: $337,674
Family Medicine $337,674
Jeannette Potts, Md, MD
Family Medicine — Payments: $30,044
Family Medicine $30,044
Meaghan Combs, Md, MD
Family Medicine — Payments: $25,727
Family Medicine $25,727
George Stokes, Md, MD
Family Medicine — Payments: $18,678
Family Medicine $18,678
Dr. Charles Brock, M.d, M.D
Family Medicine — Payments: $9,519
Family Medicine $9,519
Mr. Cecil Breetzke, Md, MD
Family Medicine — Payments: $9,499
Family Medicine $9,499